UCB Pharma S.A., commonly referred to as UCB, is a global biopharmaceutical company headquartered in Belgium. Founded in 1928, UCB has established itself as a leader in the biopharmaceutical industry, focusing on the development of innovative therapies for neurological and immunological disorders. With a strong presence in Europe and North America, UCB is dedicated to improving the lives of patients through its core products, including treatments for epilepsy, rheumatoid arthritis, and Crohn's disease. UCB's commitment to research and development has led to significant milestones, including the launch of several groundbreaking therapies that address unmet medical needs. The company is recognised for its patient-centric approach and robust pipeline, positioning it as a key player in the global healthcare landscape. With a focus on innovation and collaboration, UCB continues to make strides in advancing biopharmaceutical solutions.
We don't have data for UCB Pharma S.A., but we can show you information about their parent organization instead.
View parent company